ICRF has awarded more than $100 million in funding to support nearly 3,000 grants to outstanding cancer researchers at all leading institutions in Israel as well as collaborative research partnerships between Israeli and North American investigators. Many of our grantees are responsible for major cancer research breakthroughs and discoveries.

Recipient(s) Institution Grant Type Research Topics Grant Status
Moshe Giladi, MD, PhD Tel Aviv University Research Career Development Award Cancer Metastasis, Gastrointestinal Cancer, Lung Cancer, Metabolism and Cancer, Oncogenesis, Proteomics and Protein Structures Non-active
Nir London, PhD The Weizmann Institute of Science Project Grant Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Pediatric Cancer Active
Ariel Munitz, PhD Tel Aviv University Project Grant Cancer Metastasis, Immunology and Immunotherapy, Lung Cancer, Microenvironment Active
Lior Nissim, PhD Hebrew University of Jerusalem ICRF-Cancer Research Institute Immunotherapy Promise Grant Clinical and Translational Research, Immunology and Immunotherapy, Lung Cancer, Synthetic Gene Circuits Non-active
Angel Porgador, PhD Ben-Gurion University of the Negev Acceleration Grant Head and Neck Cancer, Immunology and Immunotherapy, Kidney Cancer, Lung Cancer Non-active
Ronit Satchi-Fainaro, PhD Tel Aviv University Research Professorship Grant Brain Cancer, Breast Cancer, Cancer Metastasis, Immunology and Immunotherapy, Lung Cancer, Nanotechnology Non-active
Ravid Straussman, MD, PhD Weizmann Institute of Science ICRF-City of Hope Jacki and Bruce Barron Cancer Research Scholars’ Program Grant Lung Cancer, Non-Small Cell Lung Cancer Non-active
Yosef Yarden, PhD Weizmann Institute of Science Project Grant Drug Resistance, Experimental Therapeutics, Non-Small Cell Lung Cancer Non-active
Yosef Yarden, PhD Weizmann Institute of Science Project Grant Non-Small Cell Lung Cancer Active
Joel Yisraeli, PhD Hebrew University of Jerusalem Project Grant Lung Cancer, Targeted Therapies Non-active